LT - N-(3-metoksi-5-metilpirazin-2-il)-2-(4-[1,3,4-oksadiazol-2-il]fenil)piridin-3-sulfonamido etanolamino druska
EN - ETHANOLAMINE SALT OF N- (3-METHOXY-5-METHYLPYRAZIN-2YL) -2- (4- [1 , 3 , 4-0XADIAZ0LE-2-YL]PHENYL) PYRIDINE-3- SULPHONAMIDE
Legal status
Patent lapsed (non-payment of fees)
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
C07D 413/14 |
(2006.01) |
|
|
A61K 31/497 |
(2006.01) |
|
|
A61P 35/04 |
(2006.01) |
European patent
(11) |
Number of the document |
1904490 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
06755779.3 |
|
Date of filing the European patent application |
2006-07-17 |
(97) |
Date of publication of the European application |
2008-04-02 |
(45) |
Date of publication and mention of the grant of the patent |
2010-09-29
|
(46) |
Date of publication of the claims translation |
2010-12-27
|
PCT application
(86) |
Number |
PCT/GB2006/002654 |
|
Date |
2006-07-17 |
PCT application publication
(87) |
Number |
WO 2007/010235 |
|
Date |
2007-01-25 |
Priority applications
(30) |
Number |
Date |
Country code |
|
0514743 |
2005-07-19
|
GB |
Inventors
(72) |
GOOD, Catherine, GB
HOGAN, Phillip John, GB
MONTGOMERY, Frank, GB
|
Grantee
(73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
Attorney or representative
(74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
Title
(54) |
N-(3-metoksi-5-metilpirazin-2-il)-2-(4-[1,3,4-oksadiazol-2-il]fenil)piridin-3-sulfonamido etanolamino druska |
|
ETHANOLAMINE SALT OF N- (3-METHOXY-5-METHYLPYRAZIN-2YL) -2- (4- [1 , 3 , 4-0XADIAZ0LE-2-YL]PHENYL) PYRIDINE-3- SULPHONAMIDE |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2012-06-19 |
7 |
560.00
LTL
|
Legal status
|
Patent lapsed (non-payment of fees)
|
|
|
Invalidation date |
2013-07-17 |